ACCELERON PHARMA INC Insider Trading for January 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACCELERON PHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACCELERON PHARMA INC for January 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | Veness Adam M | SVP, General Counse ... | Sell | S | 124.30 | 100 | 12,430 | 16,163 | 16.3 K to 16.2 K (-0.61 %) |
Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | Veness Adam M | SVP, General Counse ... | Sell | S | 122.93 | 56 | 6,884 | 16,263 | 16.3 K to 16.3 K (-0.34 %) |
Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | Veness Adam M | SVP, General Counse ... | Sell | S | 122.46 | 1,900 | 232,674 | 16,319 | 18.2 K to 16.3 K (-10.43 %) |
Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | Veness Adam M | SVP, General Counse ... | Payment of Exercise | F | 124.31 | 942 | 117,100 | 18,219 | 19.2 K to 18.2 K (-4.92 %) |
Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | EVP, Chief Commerci ... | Sell | S | 126.15 | 4,624 | 583,318 | 3,987 | 8.6 K to 4 K (-53.70 %) |
Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | EVP, Chief Commerci ... | Sell | S | 125.17 | 3,429 | 429,208 | 8,611 | 12 K to 8.6 K (-28.48 %) |
Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | EVP, Chief Commerci ... | Sell | S | 123.90 | 1,947 | 241,233 | 12,040 | 14 K to 12 K (-13.92 %) |
Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | KANGO SUJAY | EVP, Chief Commerci ... | Payment of Exercise | F | 124.31 | 1,357 | 168,689 | 13,987 | 15.3 K to 14 K (-8.84 %) |
Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | Backstrom Jay T. | EVP, Research and D ... | Payment of Exercise | F | 124.31 | 1,735 | 215,678 | 15,372 | 17.1 K to 15.4 K (-10.14 %) |
Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 123.50 | 4 | 494 | 5,813 | 5.8 K to 5.8 K (-0.07 %) |
Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 122.85 | 296 | 36,364 | 5,817 | 6.1 K to 5.8 K (-4.84 %) |
Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 121.89 | 499 | 60,823 | 6,113 | 6.6 K to 6.1 K (-7.55 %) |
Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 120.43 | 700 | 84,301 | 6,612 | 7.3 K to 6.6 K (-9.57 %) |
Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 124.45 | 300 | 37,335 | 7,312 | 7.6 K to 7.3 K (-3.94 %) |
Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 124.47 | 667 | 83,021 | 7,612 | 8.3 K to 7.6 K (-8.06 %) |
Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 123.49 | 600 | 74,094 | 8,279 | 8.9 K to 8.3 K (-6.76 %) |
Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 125.49 | 200 | 25,098 | 8,879 | 9.1 K to 8.9 K (-2.20 %) |
Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 124.28 | 713 | 88,612 | 9,079 | 9.8 K to 9.1 K (-7.28 %) |
Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 123.54 | 800 | 98,832 | 9,792 | 10.6 K to 9.8 K (-7.55 %) |
Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Payment of Exercise | F | 124.31 | 624 | 77,569 | 10,592 | 11.2 K to 10.6 K (-5.56 %) |
Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | Dable Habib J | CEO and President | Sell | S | 122.55 | 94 | 11,520 | 81,788 | 81.9 K to 81.8 K (-0.11 %) |
Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | Dable Habib J | CEO and President | Sell | S | 122.46 | 764 | 93,559 | 81,882 | 82.6 K to 81.9 K (-0.92 %) |
Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | Dable Habib J | CEO and President | Sell | S | 121.55 | 900 | 109,395 | 82,646 | 83.5 K to 82.6 K (-1.08 %) |
Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | Dable Habib J | CEO and President | Sell | S | 120.52 | 2,500 | 301,300 | 83,546 | 86 K to 83.5 K (-2.91 %) |
Jan 06 2021 | XLRN | ACCELERON PHARMA I ... | Dable Habib J | CEO and President | Payment of Exercise | F | 124.31 | 3,278 | 407,488 | 86,046 | 89.3 K to 86 K (-3.67 %) |